Hb A₂-Zagreb Or α₂δ₂125(H3)Gln→Lglu, A New δ Chain Variant in Association with δβ-Thalassemia

D. Juricic Departments of Clinical Chemistry, Internal Medicine Clinical Hospital “Dr. O. Novosel”, Zagreb, Yugoslavia

I. Crepinko Departments of Clinical Chemistry, Internal Medicine Clinical Hospital “Dr. O. Novosel”, Zagreb, Yugoslavia

G. D. Efremov National Reference Laboratory for Hemoglobinopathies ZF University of Skopje, Skopje, Yugoslavia

H. Lam Laboratory of Protein Chemistry and Comprehensive Sickle Cell Center Department of Cell, Molecular Biology Medical College of Georgia, Augusta, GA, 30912, USA

B. B. Webber Laboratory of Protein Chemistry and Comprehensive Sickle Cell Center Department of Cell, Molecular Biology Medical College of Georgia, Augusta, GA, 30912, USA

M. G. Headlee Laboratory of Protein Chemistry and Comprehensive Sickle Cell Center Department of Cell, Molecular Biology Medical College of Georgia, Augusta, GA, 30912, USA

T. H. J. Huisman Laboratory of Protein Chemistry and Comprehensive Sickle Cell Center Department of Cell, Molecular Biology Medical College of Georgia, Augusta, GA, 30912, USA

show all

Hb A₂-Zagreb Or α₂δ₂125(H3)Gln→Lglu, A New δ Chain Variant in Association with δβ-Thalassemia

Information for

Open access

Opportunities

Help and information

Hb A2-Zagreb Or α2δ2125(H3)Gln→Lglu, A New δ Chain Variant in Association with δβ-Thalassemia

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature

Hb A₂-Zagreb Or α₂δ₂125(H3)Gln→Lglu, A New δ Chain Variant in Association with δβ-Thalassemia